跳至主要内容
临床试验/CTRI/2024/01/061097
CTRI/2024/01/061097尚未招募3 期

Efficacy and safety of carbetocin versus oxytocin in prevention of post partum hemorrhage in high risk women.
An Open label randomised controlled trial

DR SMRITI BAG1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年1月9日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
The total amount of blood loss within 24 hours postpartum measured by V drapes

研究概览

简要总结

Ethical clearance and informed consent will be done.

Information on age, education, parity, occupation and obstetric history was obtained from the mother using a questionnaire

Using a computer generated randomisation sequence, women eligible in the study will be randomly divided into two equal groups with at least one risk factor and a prospective open blinded randomised study will be conducted on 120 (60 in each group) pregnant women divided equally between two groups

  • Group 1- Oxytocin group
  • Group 2 - Carbetocin group

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • Women of age between 18-35 years of Gestational age of 37-42 weeks Patients who have given written informed consent Women at risk of PPH including Factors resulting in overdistention of the uterus Multiple gestation (eg, twins) Fetal macrosomia Polyhydramnios Nature of labor and delivery Induced labor Precipitous labor (lasting less than 3 hours) Prolonged labor Forceps or vacuum-assisted delivery Cesarean delivery Factors relating to the placenta Abruptio placentae Placenta previa Abnormal implantation High multiparity 
 Preeclampsia Chorioamnionitis  Amniotic fluid embolism May precipitate disseminated intravascular coagulation, resulting in consumptive coagulopathy and uncontrolled blood loss Under general Anesthesia Medications Prolonged oxytocin use Magnesium sulfate Anticoagulants.

排除标准

  • Gestational age less than 37 or more than 42 weeks History of thromboembolic disorders, Cases suffering from chronic medical diseases (cardiac, hepatic, renal), Not giving consent.

结局指标

主要结局

The total amount of blood loss within 24 hours postpartum measured by V drapes

时间窗: The total amount of blood loss within 24 hours postpartum measured by V drapes

Adverse maternal events like nausea vomiting tachycardia flushing dizziness headache shivering metallic taste dyspnea palpitations itching

时间窗: The total amount of blood loss within 24 hours postpartum measured by V drapes

Hemodynamic status will be measured at 0 min 30 min 60min 120 min

时间窗: The total amount of blood loss within 24 hours postpartum measured by V drapes

次要结局

  • Need for second line uterotonics and interventions(Need of blood and blood products)

研究者

发起方
DR SMRITI BAG
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

SMRITI BAG

KING GEORGE MEDICAL COLLEGE AND UNIVERSITY

研究点 (1)

Loading locations...

相似试验